Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation

Gut

Volumn 63, Issue 3, 2014, Pages 492-493

  Lourenço, Filipe C ^a   Munro, June ^a   Brown, Jennifer ^a   Cordero, Julia ^a   Stefanatos, Rhoda ^a   Strathdee, Karen ^a   Orange, Clare ^b   Feller, Stephan M ^c   Sansom, Owen J ^a   Vidal, Marcos ^a   Murray, Graeme I ^d   Olson, Michael F ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b Division of Cancer Sciences and Molecular Pathology   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIM KINASE; LIMK2 PROTEIN, HUMAN; LIMK2 PROTEIN, MOUSE; TUMOR MARKER;

ACTIN FILAMENT; ANIMAL; ARTICLE; CANCER STEM CELL; CELL PROLIFERATION; CELL SIGNALLING; COLON; COLORECTAL TUMOR; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; DNA METHYLATION; DOWN REGULATION; DROSOPHILA MELANOGASTER; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; TISSUE MICROARRAY; TUMOR CELL LINE;

ACTIN CYTOSKELETON; CELL SIGNALLING; GASTROINTESTINAL CANCER; SIGNAL TRANSDUCTION; STEM CELLS;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; DROSOPHILA MELANOGASTER; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LIM KINASES; MICE; MICE, KNOCKOUT; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893816802     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303883     Document Type: Article

References (56)

1. Davies EJ, Marsh V, Clarke AR. Origin and maintenance of the intestinal cancer stem cell. Mol Carcinog 2011;50:254-63.
2. Schepers AG, Snippert HJ, Stange DE, et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012;337:730-5.
3. Barker N, Ridgway RA, van Es JH, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608-11.
4. Merlos-Suarez A, Barriga FM, Jung P, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011;8:511-24.
5. Ziskin JL, Dunlap D, Yaylaoglu M, et al. In situ validation of an intestinal stem cell signature in colorectal cancer. Gut 2013;62:1012-23.
6. Olson MF, Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis 2009;26:273-87.
7. Samuel MS, Olson MF. Dying alone: a tale of rho. Cell Stem Cell 2010;7:135-6.
8. Scott RW, Olson MF. LIM kinases: function, regulation and association with human disease. J Mol Med 2007;85:555-68. (Pubitemid 46870893)
9. Manetti F. Recent findings confirm LIM domain kinases as emerging target candidates for cancer therapy. Curr Cancer Drug Targets 2012;12:543-60.
10. Bagheri-Yarmand R, Mazumdar A, Sahin AA, et al. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int J Cancer 2006;118:2703-10. (Pubitemid 43673347)
11. McConnell BV, Koto K, Gutierrez-Hartmann A. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression. Mol Cancer 2011;10:75.
12. Okamoto I, Pirker C, Bilban M, et al. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. Neoplasia 2005;7:303-11. (Pubitemid 40664219)
13. Davila M, Frost AR, Grizzle WE, et al. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 2003;278:36868-75. (Pubitemid 37140021)
14. D'Abaco GM, Olson MF. Mouse embryo fibroblasts: a genetic model system for studying Rho-and Ras-dependent cell cycle progression. Methods Enzymol 2000;325:415-25.
15. Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009;459:262-5.
16. Emaduddin M, Bicknell DC, Bodmer WF, et al. Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells. Proc Natl Acad Sci U S A 2008;105:2358-62. (Pubitemid 351520518)
17. Croft DR, Crighton D, Samuel MS, et al. p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival. Cell Res 2011;21:666-82.
18. Samuel MS, Munro J, Bryson S, et al. Tissue selective expression of conditionally-regulated ROCK by gene targeting to a defined locus. Genesis 2009;47:440-6.
19. Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-7. (Pubitemid 350014593)
20. Cordero JB, Macagno JP, Stefanatos RK, et al. Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter. Dev Cell 2010;18:999-1011.
21. O'Dwyer D, Ralton LD, O'Shea A, et al. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis. PLoS One 2011;6: e27718.
22. Hope NR, Murray GI. The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum Pathol 2011;42:393-402.
23. Murray GI, Patimalla S, Stewart KN, et al. Profiling the expression of cytochrome P450 in breast cancer. Histopathology 2010;57:202-11.
24. Foulks JM, Parnell KM, Nix RN, et al. Epigenetic drug discovery: targeting DNA methyltransferases. J Biomol Screen 2012;17:2-17.
25. Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004;6:1-6. (Pubitemid 38391943)
26. Kaiser S, Park YK, Franklin JL, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 2007;8:R131.
27. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.
28. Skrzypczak M, Goryca K, Rubel T, et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One 2010;5:e13091.
29. Hong Y, Downey T, Eu KW, et al. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 2010;27:83-90.
30. Samuel MS, Lopez JI, McGhee EJ, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011;19:776-91.
31. Marsh V, Winton DJ, Williams GT, et al. Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Nat Genet 2008;40:1436-44.
32. Conway C, Dobson L, O'Grady A, et al. Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs. Histochem Cell Biol 2008;130:447-63.
33. Mohammed ZM, Going JJ, McMillan DC, et al. Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer. Histopathology 2012;61:675-84.
34. Polesello C, Roch F, Gobert V, et al. Modeling cancers in Drosophila. Prog Mol Biol Transl Sci 2011;100:51-82.
35. Rudrapatna VA, Cagan RL, Das TK. Drosophila cancer models. Dev Dyn 2012;241:107-18.
36. Cordero JB, Sansom OJ. Wnt signalling and its role in stem cell-driven intestinal regeneration and hyperplasia. Acta physiol 2012;204:137-43.
37. Lee WC, Beebe K, Sudmeier L, et al. Adenomatous polyposis coli regulates Drosophila intestinal stem cell proliferation. Development 2009;136:2255-64.
38. Lin G, Xu N, Xi R. Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells. Nature 2008;455:1119-23.
39. Cordero J, Vidal M, Sansom O. APC as a master regulator of intestinal homeostasis and transformation: from flies to vertebrates. Cell Cycle 2009;8:2926-31.
40. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993;118:401-15. (Pubitemid 23214028)
41. Micchelli CA, Perrimon N. Evidence that stem cells reside in the adult Drosophila midgut epithelium. Nature 2006;439:475-9. (Pubitemid 43152838)
42. Jiang H, Patel PH, Kohlmaier A, et al. Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut. Cell 2009;137:1343-55.
43. Okayasu I, Ohkusa T, Kajiura K, et al. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996;39:87-92. (Pubitemid 26239112)
44. Jiang H, Edgar BA. Intestinal stem cells in the adult Drosophila midgut. Exp Cell Res 2011;317:2780-8.
45. Scott RW, Hooper S, Crighton D, et al. LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol 2010;191:169-85.
46. Hsu FF, Lin TY, Chen JY, et al. p53-Mediated transactivation of LIMK2b links actin dynamics to cell cycle checkpoint control. Oncogene 2010;29:2864-76.
47. Heng YW, Lim HH, Mina T, et al. TPPP acts downstream of RhoA-ROCK-LIMK2 to regulate astral microtubule organization and spindle orientation. J Cell Sci 2012;125:1579-90.
48. Sumi T, Hashigasako A, Matsumoto K, et al. Different activity regulation and subcellular localization of LIMK1 and LIMK2 during cell cycle transition. Exp Cell Res 2006;312:1021-30.
49. Sahai E, Olson MF, Marshall CJ. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. Embo J 2001;20:755-66. (Pubitemid 32167640)
50. Zebda N, Bernard O, Bailly M, et al. Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension. J Cell Biol 2000;151:1119-28.
51. Wang W, Mouneimne G, Sidani M, et al. The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 2006;173:395-404.
52. Oser M, Condeelis J. The cofilin activity cycle in lamellipodia and invadopodia. J Cell Biochem 2009;108:1252-62.
53. van Rheenen J, Condeelis J, Glogauer M. A common cofilin activity cycle in invasive tumor cells and inflammatory cells. J Cell Sci 2009;122:305-11.
54. Johnson EO, Chang KH, Ghosh S, et al. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. J Cell Sci 2012;125:1204-16.
55. Mashiach-Farkash E, Rak R, Elad-Sfadia G, et al. Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton. Oncotarget 2012;3:629-39.
56. Po'uha ST, Shum MS, Goebel A, et al. LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs. Oncogene 2010;29:597-607.